1. Bowers, M. B. (1974). Central dopamine turnover in schizophrenic syndromes. Arch. Gen. Psychiatry, 31, 50
2. Carlton, P. L. (1968). Cholinergic mechanisms in the control of behaviour bv the brain. In Psychopharmacology—a Review of Progress 1957–1967. D. H. Efron et al. (eds.) pp. 125–135 (Washington, D.C.: U. S. Government Printing Office)
3. Cole, J. O. and Davis, J. M. (1968). Clinical efficacy of the phenothiazines as antipsychotic drugs. In Psychopharmacology—a Review of Progress 1957–1967. D. H. Efron, et al. (eds.) pp. 1057–1063 (Washington, D.C.: U. S. Government Printing Office)
4. Colpaert, F. C., Wauquier, A., Niemegeers, C. J. E. and Lal, H (1975). Reversal by a central anticholinergic drug of pimozide-induced inhibition of mouse jumping in amphetamine dopa-treated mice. J. Pharm. Pharmacol. 27, 536
5. Elkes, J. (1961). Schizophrenic disorder in relation to levels of neural organisation: The need for some conceptual points of reference. In The Clinical Pathology of Nervous System. J. Folch-Pi (ed.) pp. 648–665. (London: Pergamon Press)